Apollo Hospitals Announces Strong Q3FY26 Results
Chennai, India Feb 11: Apollo Hospitals Enterprise Ltd. (AHEL) today announced its financial results for the third quarter ended December 31, 2025, reporting robust growth across all three business verticals and on a consolidated basis. The company also declared an interim dividend of Rs 10 per equity share.
Apollo continued its expansion momentum with the Phase 1 launch of a 250-bed quaternary care hospital in Pune, marking a significant step toward its planned 400-bed capacity in the region. The quarter also saw notable progress in clinical excellence, transplant leadership, and international patient services.
Q3FY26 Consolidated Financial Highlights
- Revenue: Rs 6,477 crore (↑17% YoY)
- EBITDA: Rs 965 crore (↑27% YoY)
- PAT: Rs 502 crore (↑35% YoY)
- Diluted EPS: Rs 34.94 (not annualized)
- Apollo 24/7 GMV: Rs 525 crore
YTD (Dec FY26) Consolidated Performance
- Revenue: Rs 18,623 crore (↑15% YoY)
- EBITDA: Rs 2,758 crore (↑22% YoY)
- PAT: Rs 1,412 crore (↑34% YoY)
- Diluted EPS: Rs 98.23 (not annualized)
- Apollo 24/7 GMV: Rs 1,508 crore
Leadership Commentary
Dr. Prathap C. Reddy, Chairman, Apollo Hospitals Enterprise Ltd., said: “Q3FY26 reflects the fundamental strength and clinical depth of Apollo’s integrated care model. Sustained investments in advanced clinical capabilities have translated into measurable progress across key specialties. From robotic joint replacement milestones to the expansion of advanced stroke labs and transplant infrastructure, our teams continue to deliver superior outcomes anchored in safety, ethics, and long-term patient impact.
As one of the world’s busiest solid organ transplant programmes, we now perform an average of five transplants daily. With over 21,000 kidney and 5,000 liver transplants completed, Apollo remains at the forefront of global transplant excellence.
We view Medical Value Travel as a national mission and will continue working closely with policymakers to strengthen India’s global healthcare leadership.”
Capacity Expansion: Pune Quaternary Hospital Launch
Apollo inaugurated a state-of-the-art 250-bed quaternary care hospital in Pune, integrating:
- Advanced surgical robotics
- Precision oncology
- 100+ ICU beds
- IoT-enabled monitoring systems
- Multidisciplinary high-acuity programs
The facility strengthens Apollo’s presence in Western India and enhances capacity for complex, technology-enabled care.
Clinical Excellence & Transplant Leadership
Apollo sustained its position as the world’s busiest solid organ transplant program, performing an average of five transplants daily.
Key Milestones:
- Bilateral lung transplant in Chennai using metro-rail organ transport (Tamil Nadu first)
- Successful liver transplant in Trichy with 190 km organ transport in 2.5 hours
- Rapid 20-minute live heart transfer in Bengaluru via metro rail
- 48 bone marrow transplants completed YTD Dec FY26 at Apollo Kolkata (~50% international cases)
Cumulative transplant record includes:
- 21,000+ kidney transplants
- 5,000+ liver transplants
- 159 heart transplants
- 232 lung transplants
Business Vertical Performance
- Healthcare Services (Hospitals)
- Revenue: Rs 3,183 crore (↑14% YoY)
- EBITDA: Rs 790 crore (↑18% YoY)
- EBITDA Margin: 24.8%
- Operating Beds: 8,072
- Occupancy: 67%
Strong revenue growth was recorded across Tamil Nadu, AP Telangana, Karnataka, Eastern, Western, and Northern regions, driven by ARPP growth and high-acuity procedures.
- Apollo Health & Lifestyle Ltd. (AHLL)
- Revenue: Rs 467 crore (↑20% YoY)
- EBITDA: Rs 48 crore (↑39% YoY)
- Margin: 10.2%
Apollo HealthCo (Omni-channel Pharmacy & Digital)
- Revenue: Rs 2,827 crore (↑20% YoY)
- EBITDA: Rs 128 crore
- 185 net new stores added (Total: 7,113 stores)
- Avg. daily order run rate: 57,000
- Breakthrough Clinical Achievements
Gene therapy success in a 13-month-old SMA Type 1 patient at Apollo Children’s Hospital, Chennai
- Tamil Nadu’s first dual-chamber leadless pacemaker implantation
- Launch of Centre of Excellence for Parkinson’s & Deep Brain Stimulation (DBS)
- Largest stroke care network expansion in Chennai
- Record robotic surgical throughput in Bengaluru
- First combined TAVI and angioplasty in Northeast India (Guwahati)
- Strategic Partnerships & Initiatives
- MoU with Coal India to expand workforce healthcare access
- Launch of ‘Save My Stomach’ early detection oncology program
- Expansion of robotic surgery centers in Delhi
- Strengthened Medical Value Travel ecosystem
- Corporate Social Responsibility
Through the Billion Hearts Beating (BHB) and Total Health (TH) initiatives, Apollo Foundation reached 276,369 beneficiaries in Q3FY26, scaling preventive healthcare delivery through technology-enabled, outcome-driven models.